Pluristem Therapeutics, Inc. (PSTI)

Recent Material Events for Pluristem Therapeutics, Inc.
Date Description
Jan 15, 2013 On January 15, 2013, the registrant announced that it had received an approval from the Paul-Ehrlich-Institute, the medical regulatory body for biological medicinal products for the Federal Republic of Germany, to commence a Phase II study using PLX-
Dec 26, 2012 On December 26, 2012, Pluristem Therapeutics Inc., or Pluristem, entered into an At Market Issuance Sales Agreement, or the Sales Agreement, with MLV & Co. LLC, or MLV, pursuant to which Pluristem may issue and sell shares of its common stock hav
Dec 26, 2012 On December 26, 2012, Pluristem Therapeutics Inc., or Pluristem, entered into an At Market Issuance Sales Agreement, or the Sales Agreement, with MLV & Co. LLC, or MLV, pursuant to which Pluristem may issue and sell shares of its common stock hav
Nov 09, 2012 On November 9, 2012, the registrant issued a press release commenting on an article published on Bloomberg.com on November 7, 2012. A copy of the press release is filed as exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by ref
Oct 09, 2012 On October 9, 2012, the registrant issued a letter to its shareholders as of that date. The letter is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Oct 09, 2012 On October 9, 2012, the registrant issued a letter to its shareholders as of that date. The letter is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Sep 19, 2012 Pluristem Therapeutics Inc., or the Company, hereby files an updated form of a warrant agreement, or Warrant Agreement, to be entered into between the Company and American Stock Transfer & Trust Company, LLC. The Warrant Agreement is being refile
Sep 19, 2012 Pluristem Therapeutics Inc., or the Company, hereby files an updated form of a warrant agreement, or Warrant Agreement, to be entered into between the Company and American Stock Transfer & Trust Company, LLC. The Warrant Agreement is being refile
Sep 14, 2012 On September 13, 2012, Pluristem Therapeutics Inc., or the Company, entered into an underwriting agreement, or the Underwriting Agreement, with Jefferies & Company, Inc., as representative of the underwriters named therein, in connection with a p
Sep 14, 2012 On September 13, 2012, Pluristem Therapeutics Inc., or the Company, entered into an underwriting agreement, or the Underwriting Agreement, with Jefferies & Company, Inc., as representative of the underwriters named therein, in connection with a p